Guy G. Brusselle

Dec 5, 2024 | publications.ersnet.org | Michael E. Wechsler |Guy G. Brusselle |J. Christian Virchow |Arnaud Bourdin

IntroductionGlobally, ∼262 million people are affected by asthma [1], resulting in a significant healthcare and economic burden [2]. Asthma is a heterogeneous, chronic lung disease that affects both adults and children [2]. Different underlying disease processes give rise to multiple clinical asthma phenotypes, thereby contributing to the complexity of treatment strategies, particularly because many patients with asthma have overlapping phenotypes (e.g. both eosinophilic and allergic) [3].

Sep 26, 2024 | erj.ersjournals.com | Michael E. Wechsler |Guy G. Brusselle |J. Christian Virchow |Stephanie Roseti

FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of Interest: A. Versi has nothing to disclose.

Sep 7, 2023 | erj.ersjournals.com | Alberto Papi |Richard Beasley |Guy G. Brusselle |Courtney Coleman

FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.